South San Francisco
California, United States of America
Genentech/Roche is seeking a Principal Medical Director to join the Inflammatory Bowel Disease group within Product Development Immunology, Infectious Disease, and Ophthalmology. The individual will play a leadership role in developing and executing the long-range plans for etrolizumab, collaborating with early clinical development and partnering to advance molecules into the late stage portfolio, and shaping the company’s inflammatory bowel disease strategy. The Principal Medical Director for Inflammatory Bowel Disease (IBD) is expected to be a standing member of the Development Review Committee for molecules in this disease area. IBD is a disease area of high interest and investment at Roche. Roche has a rich IBD pipeline at various stages of development, including etrolizumab which has a large ongoing Phase 3 program, IL-22 which is currently in Phase 2b development, and multiple Phase 1 and research assets.
A member of the Roche Group, Genentech has been at the forefront of the biotechnology industry for more than 40 years, using human genetic information to develop novel medicines for serious and life-threatening diseases. Genentech has multiple therapies on the market for cancer & other serious illnesses. Please take this opportunity to learn about Genentech where we believe that our employees are our most important asset & are dedicated to remaining a great place to work.
The next step is yours. To apply today, click on the "Apply online" button.
Genentech is an equal opportunity employer & prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital & veteran status. For more information about equal employment opportunity, visit our Genentech Careers page.
At Genentech, we share salary ranges with applicants during the recruiting process, if requested. Third party salary estimates may not be accurate or up-to-date.
These are our stories - stories of the obstacles and opportunities that define and celebrate the unique people at Genentech